Genetic Background Drives Transcriptional Variation in Human Induced Pluripotent Stem Cells
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Human iPS cells have been generated using a diverse range of tissues from a variety of donors using different reprogramming vectors. However, these cell lines are heterogeneous, which presents a limitation for their use in disease modeling and personalized medicine. To explore the basis of this heterogeneity we generated 25 iPS cell lines under normalised conditions from the same set of somatic tissues across a number of donors. RNA-seq data sets from each cell line were compared to identify the majority contributors to transcriptional heterogeneity. We found that genetic differences between individual donors were the major cause of transcriptional variation between lines. In contrast, residual signatures from the somatic cell of origin, so called epigenetic memory, contributed relatively little to transcriptional variation. Thus, underlying genetic background variation is responsible for most heterogeneity between human iPS cell lines. We conclude that epigenetic effects in hIPSCs are minimal, and that hIPSCs are a stable, robust and powerful platform for large-scale studies of the function of genetic differences between individuals. Our data also suggest that future studies using hIPSCs as a model system should focus most effort on collection of large numbers of donors, rather than generating large numbers of lines from the same donor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Genetic effects on transcription in iPSCs. (a) Variance component of known eQTL genes showing primary eQTL SNPs being able to explain 17% of FPKM variation on average. Top and bottom 3,000 eQTL genes and SNPs were determined by means of P-values using gEUVADIS RNA-seq data [27]. (b) Box- plot of log2 FPKM aggregated across 462 eQTL genes (FDR 5%) stratified into high (+/+), medium (+/−) and low (−/−) genotypes at the minimum p-value eQTL SNPs ascertained from [2] (FDR 5%). Pearson correlation r = 0.44, p<9.8×10−68. (c) Boxplot of allelic imbalance at high-expression (+) and low-expression (−) haplotypes across all eQTL genes ascertained from [2]. The red line is at 0.5 indicating the expected fraction under the null. Student t p<1.3×10−8. (d) Mean RNA-Seq coverage depth in iPSCs, averaged across all iPSC lines from each individual, at a putative example eQTL for the noncoding RNA SNHG5 gene. Individuals are grouped by their genotype at the putatively causal variant rs1059307. Individual genotypes are shown with the number of RNA-seq samples in parentheses. (e) Average coverage depth of fragments coming from the high-expression haplotype (allele T) and low- expression haplotype (allele G) at rs1059307. (f) eQTL association of SNHG5 gene at rs1059307 in lymphoblastoid cell lines from [2] showing distributions of log2 FPKM against SNP genotypes at rs1059307. The red line shows the best-fit linear regression line.](https://figures.cochat.ai/paper-figures/96597e1d7aa9463aababb4bb7d7946f0/genetic-background-drives-transcriptional-variation-in-human-induced-pluripotent-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reprogramming, for example, a given somatic cell type from a given donor, using a given reprogramming method and culture platform, may give rise to iPSC colonies that are different in their expansion rate, robustness (the tendency to spontaneously differentiate in culture), and potential to be differentiated directly to specific lineages [56,57,58,59,60].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Nevertheless, keeping the above parameters the same still results in iPSC colonies that are different from each other.”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · cited 2×
“We mapped reads to assembly h37 of the human genome using Bowtie2 [14] and constructed spliced alignments using Tophat2 [15].”
MethodInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668 · cited 1×
“We mapped reads to assembly h37 of the human genome using Bowtie2 [14] and constructed spliced alignments using Tophat2 [34] with default settings.”
MethodTopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248 · cited 1×
“Principal component analysis was performed using Eigenstrat [35] with genome-wide SNP genotypes of European populations obtained from 1000 Genomes Project.”
MethodEpigenetic memory in induced pluripotent stem cells
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R., et al. (2010) · Nature · doi:10.1038/nature09342 · Cited by 2,313 · cited 1×
“We note, however, that other studies that have also explicitly controlled for genetic background still report some variation in transcription, methylation and differentiation efficiencies that appear to arise from cell type of origin effects [5,8,10].”
ResultTranscriptome and genome sequencing uncovers functional variation in humans
The Geuvadis Consortium, Lappalainen, T., Sammeth, M., Friedländer, M. R., ‘t Hoen, P. A. C., Monlong, J., Rivas, M. A., Gonzàlez-Porta, M., Kurbatova, N., Griebel, T., et al. (2013) · Nature · doi:10.1038/nature12531 · Cited by 1,888 · cited 2×
“Top and bottom 3,000 eQTL genes and SNPs were determined by means of P-values using gEUVADIS RNA-seq data [27].”
MethodBrowning, B. L., & Browning, S. R. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.01.005 · Cited by 1,640 · cited 2×
“5-8 BeadChip, followed by imputation with the 1000 Genomes Project data and haplotype phasing using Beagle software [5].”
Method
Cited by
Items 201–299 of 299
Li, J., Yin, X., & Luan, Q. (2018) · Journal of Periodontology · doi:10.1002/jper.18-0033 · Cited by 9
Janz, A., Walz, K., Cirnu, A., Surjanto, J., Urlaub, D., Leskien, M., Kohlhaas, M., Nickel, A. G., Brand, T., Nose, N., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101859 · Cited by 10
“Substrate utilization,Ca 2 þ handling and arrhythmias appear to be more variable between the different mutant conditions possibly also due to modifying factors such as the genetic background, but also culture conditions and the limitations of the in vitro model itself [48,49].”
BackgroundCharting the next century of insulin replacement with cell and gene therapies
Lau, H. H., Gan, S. U., Lickert, H., Shapiro, A. M. J., Lee, K., & Teo, A. K. K. (2021) · Med · doi:10.1016/j.medj.2021.09.001 · Cited by 10
Advances in Microfluidic Cochlea‐On‐A‐Chip
Shen, T., Han, S., He, W., Yang, W., Tang, X., Zhao, X., Liu, X., Shao, Z., Cheng, L., Zhao, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202406077 · Cited by 9
Putting induced pluripotent stem cells to the test
Vallier, L. (2015) · Nature Biotechnology · doi:10.1038/nbt.3401 · Cited by 7
Self-citationLito, S., Sidibé, A., Ilmjärv, S., Burda, P., Baumgartner, M. R., Wehrle‐Haller, B., Krause, K., & Marteyn, A. (2020) · Cells · doi:10.3390/cells9122593 · Cited by 7
“To counteract the major cause of transcriptional variation resulting from the genetic background difference between individual lines [31], we generated an isogenic control iPSC line, constitutively expressing the alpha-l-iduronidase.”
Cao, L., Schoenmaker, L., ten Den, S. A., Passier, R. C., Schwach, V., & Verbeek, F. J. (2022) · Microscopy and Microanalysis · doi:10.1093/micmic/ozac016 · Cited by 8
Meiser, I., Alstrup, M., Khalesi, E., Stephan, B., Speicher, A. M., Majer, J., Kwok, C. K., Neubauer, J. C., Hansson, M. D., & Zimmermann, H. (2023) · Cells · doi:10.3390/cells12141914 · Cited by 7
“Our studies are also evidence of cell-line-specific differences when working with hiPSCs: Different genetic backgrounds and reprogramming routines lead to different performances of both cell lines when it comes to recovery 24 h after cryopreservation, as reported in other studies [52].”
ResultYu, C., Zhang, M., Xiong, Y., Wang, Q., Wang, Y., Wu, S.-L., Hussain, S., Wang, Y., Zhang, Z., Rao, N., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-02493-5 · Cited by 8
“Moreover, iPSCs retain epigenetic marks from their somatic source, known as “epigenetic memory”, which affects their downstream differentiation ability and inclines the differentiation to their original source 8–11 .”
BackgroundPance, A., Ng, B. L., Mwikali, K., Koutsourakis, M., Agu, C. A., Rouhani, F. J., Montandon, R., Law, F., Ponstingl, H., & Rayner, J. C. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1287355 · Cited by 6
Self-citationHuman Blood-Brain-Barrier In Vitro Models: Overview and Applications
Cader, M. Z. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_562 · Cited by 7
The Defects of Epigenetic Reprogramming in Dox-Dependent Porcine-iPSCs
Jiang, A., Ma, Y., Zhang, X., Pan, Q., Luo, P., Guo, H., Wu, W., Li, J., Yu, T., & Liu, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911941 · Cited by 6
“In mouse early embryos, maternal and paternal genomes showed largely comparable allelic gene expression and allelic open chromatin landscapes; a similar imprinting pattern exists between iPSCs and their somatic cell [34].”
BackgroundKovačic, B., Rosner, M., Schlangen, K., Kramer, N., & Hengstschläger, M. (2019) · Scientific Reports · doi:10.1038/s41598-018-37491-w · Cited by 6
Molecular and Cellular Biology of Platelet Formation: Implications in Health and Disease
Italiano, J. E., & Schulze, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3 · Cited by 8
Luo, Y., Xu, Z., & Li, Z. (2025) · FASEB BioAdvances · doi:10.1096/fba.2025-00126 · Cited by 6
“Common polygenic disease risk alleles (e.g., gene loci associated with type II diabetes or Alzheimer's disease), while not directly pathogenic, may affect the long-term functional stability of differentiated cells or their response to the micro-environment [90].”
A Novel Stem Cell Model to Study Preeclampsia Endothelial Dysfunction
Wu, Y., Sun, T., Medina, P., Narasimhan, P., Stevenson, D. K., von Versen‐Höynck, F., Armstrong, J., Wu, J. C., Sayed, N., & Winn, V. D. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01590-z · Cited by 8
“Studies have shown that genetic differences between individual donors could cause transcriptional variation among iPSC lines, whereas other factors such as the reprogramming strategy or cell type of origin has a minimal role in iPSCs’ heterogeneity [41, 42].”
BackgroundKaneski, C. R., Hanover, J. A., & Schueler, U. (2022) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2022.100914 · Cited by 6
Moreau, T., Evans, A., & Ghevaert, C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8585-2_10 · Cited by 5
Genome imprinting in stem cells: A mini-review
Godini, R., Karami, K., & Fallahi, H. (2019) · Gene Expression Patterns · doi:10.1016/j.gep.2019.119063 · Cited by 6
Soeda, S., Saito, R., Fujii, A., Tojo, S., Tokumura, Y., & Taniura, H. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102351 · Cited by 5
Pandemic city: Village-in-a-dish unlocks dynamic genetic effects in the brain
Seah, C., & Brennand, K. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.02.002 · Cited by 5
Progression of differentiation of iPSCs into specific subtypes of neurons
Wang, J., Ji, R., Zhang, L., Cheng, X., & Zhang, X. (2025) · Differentiation · doi:10.1016/j.diff.2025.100869 · Cited by 4
Fransen, L. F. H., & Leonard, M. O. (2023) · Scientific Reports · doi:10.1038/s41598-023-36508-3 · Cited by 5
Arabadjiev, A., Petkova, R., Chakarov, S., Pankov, R. G., & Zhelev, N. (2014) · Biodiscovery · doi:10.7750/biodiscovery.2014.14.2 · Cited by 4
“HUES1) were later found to have some of their basic differentiation routes selectively suppressed, which could explain the low differentiation rates into particular lineages [148, 201].”
BackgroundKumar, S., Granados, J., Aceves, M., Peralta, J. M., Leandro, A. C., Thomas, J., Williams‐Blangero, S., Curran, J. E., & Blangero, J. (2024) · Cells · doi:10.3390/cells13050369 · Cited by 4
Bourque, K., Jones-Tabah, J., Mnasri, N., Martin, R., & Hébert, T. E. (2018) · Biomolecules · doi:10.3390/biom8040180 · Cited by 6
“RNA sequencing data has also shown that the variation observed in iPSCs is a consequence of the transcriptome of individuals rather than other sources, such as memory of the somatic tissue of origin [97].”
BackgroundTan, W. X., Lau, H. H., Tan, N. S., Khoo, C. M., & Teo, A. K. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822229-4.00012-7 · Cited by 4
bESC from cloned embryos do not retain transcriptomic or epigenetic memory from somatic donor cells
Navarro, M., Halstead, M. M., Rincón, G., Mutto, A. Á., & Ross, P. J. (2022) · Reproduction · doi:10.1530/rep-22-0063 · Cited by 4
New tools for experimental diabetes research: Cellular reprogramming and genome editing
Otonkoski, T. (2016) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2016.1149529 · Cited by 4
“We and others have shown that the genetic background of individual donors of iPSC has a major impact on the differentiation behavior of the stem cells (9,26).”
BackgroundPance, A., Ling, B., Mwikali, K., Koutsourakis, M., Agu, C. A., Rouhani, F. J., Ponstingl, H., Montandon, R., Law, F., & Rayner, J. C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.30.450498 · Cited by 4
“Reprogramming of Induced Pluripotent Stem cell lines Human IPS lines were derived and verified at the Wellcome Sanger Institute as described (22-25).”
MethodSelf-citationUnbiased identification of cell identity in dense mixed neural cultures
Beuckeleer, S. D., Looverbosch, T. V. D., Daele, J. V. D., Ponsaerts, P., & Vos, W. H. D. (2025) · eLife · doi:10.7554/elife.95273.4 · Cited by 5
Dinasarapu, A. R., Sutcliffe, D. J., Ozel, E., Thite, A., Grychowski, L., Visser, J. E., Hess, E. J., Kolk, S. M., & Jinnah, H. A. (2025) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szaf065 · Cited by 3
Song, C., Zhang, Z., Leng, D., He, Z., Wang, X., Liu, W., Zhang, W., Wu, Q., Zhao, Q., & Chen, G. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.07.007 · Cited by 5
“This regulation is more related to the genetic characters of individuals and reprogramming batches, but not the sex, source cell, and technical variables (Rouhani et al., 2014; Burrows et al., 2016; Carcamo-Orive et al., 2022).”
Dinasarapu, A. R., Sutcliffe, D. J., Grychowski, L., Ozel, E., Thite, A., Visser, J. E., Hess, E. J., Kolk, S. M., & Jinnah, H. A. (2025) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szaf032 · Cited by 4
“4,8,10,11,13,35 Potential iPSC colonies are then isolated from this batch by manual scraping of visible colonies or the sample is replated for isolation of individual colonies.”
Designing a blueprint for next‐generation stem cell bioprocessing development
Kim, M., & Kino‐oka, M. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27228 · Cited by 3
Production of live monkeys and their genetically matched embryonic stem cells from single embryos
Si, C., Zhu, R., Wu, J., Chen, Z., Tang, Z., Li, Z., Kang, Y., Xiang, L., Zuo, J., Yang, P., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60694-5 · Cited by 2
Translating Alzheimer’s disease proteomics into drug discovery opportunities
Drummond, E., Werry, E. L., Kavanagh, T., Genoud, S., Cho, A., Chen, S., Du, J., Hibbs, D. E., & Kassiou, M. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00035-y · Cited by 2
“High phenotype variability in iPSC models from sAD patients has been reported and is likely a reflection of different genetic backgrounds and potential ‘epigenetic memory’ of their origin [128].”
González-Fernández, V., & Sevilla, A. (2022) · Cells · doi:10.3390/cells11172714 · Cited by 2
“In contrast, inter-individual genetic variation was responsible for 38% of the total, with <1% attributable to differences between iPSCs and ESCs [8].”
BackgroundInfluentialGeneration and Maintenance of Primate Induced Pluripotent Stem Cells Derived from Urine
Radmer, J., Geuder, J., Edenhofer, F. C., Enard, W., & Ohnuki, M. (2023) · Journal of Visualized Experiments · doi:10.3791/64922 · Cited by 3
Development of an isogenic human cell trio that models polyglutamine disease
Ohno, T., Nakane, T., Akase, T., Kurasawa, H., & Aizawa, Y. (2023) · Genes & Genetic Systems · doi:10.1266/ggs.22-00030 · Cited by 2
Tijssen, M. R., Moreau, T., & Ghevaert, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3_2 · Cited by 5
Self-replicating RNA for Cellular Reprogramming in Domestic Cat
Sukparangsi, W., Ayuthaya, N. S. N., Prakongkaew, R., Karoon, S., & Thongphakdee, A. (2024) · The Thai Journal of Veterinary Medicine · doi:10.56808/2985-1130.1115 · Cited by 1
Study Models for Non-Syndromic Hearing Loss
Hoyau, V., Leclere, J.-C., & Moisan, S. (2025) · Cells · doi:10.3390/cells14211658 · Cited by 1
“However, the noise introduced by the genetic background could potentially obscure small genetic signals of interest in small samples [101].”
Epigenetic modification in congenital heart diseases by using stem cell technologies
(2015) · Stem Cell Epigenetics · doi:10.14800/sce.550 · Cited by 2
“generated 9 fibroblast-derived iPS cells, 6 keratinocyte-derived iPS cells, and 10 endothelial progenitor cell-derived iPS cells from 4 adult donors and analyzed the iPS cells, the donor cells, and 2 human ES cell lines by RNA sequencing ([70]).”
Das Kriterium der Totipotenz aus naturwissenschaftlicher Perspektive
Sgodda, S. (2014) · V&R unipress eBooks · doi:10.14220/9783737003421.13 · Cited by 2
Clinical Potential of Induced Pluripotent Stem Cells
Karagiannis, P. (2019) · Current human cell research and applications · doi:10.1007/978-981-13-3672-0_1 · Cited by 1
Induced pluripotent stem cells as models of human neurodevelopmental disorders
Jourdon, A., Mariani, J., Scuderi, S., Amiri, A., Wu, F., Yuen, E. Y., Abyzov, A. S., & Vaccarino, F. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814409-1.00005-7 · Cited by 1
Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines
Sayed, S., Sürün, D., Mircetic, J., Sidorova, O. A., & Buchholz, F. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2376-3_18 · Cited by 1
Wing, K. (2016) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · doi:10.17037/pubs.02545199
“Cell lines could be developed from gene samples obtained from cases of DILI, and a detailed analysis of the underlying cellular mechanism performed [142, 143].”
Background[Leukocyte count of puerperal sows].
Mäde, D., & Wujanz, G. (1996) · PubMed · Cited by 1
Les cellules souches pluripotentes induites : un nouveau paradigme pour l’étude des tissus humains
Sansac, C., Assou, S., Bouckenheimer, J., Lemaı̂tre, J.-M., & Vos, J. D. (2016) · Biologie Aujourd hui · doi:10.1051/jbio/2016013
“S’il existe une grande variabilit´e dans les capacit´es de diff´erenciation des CSP, cette variabilit´e n’est pas sp´ecifique aux iPSC mais partag´ee avec les CSE (Osafune et al ., 2008) et semble relever du po-lymorphisme g´en´etique (Rouhani et al ., 2014; Choi et al ., 2015).”
Re-activation of Human Endogenous Retrovirus-K in Neuroinflammatory Disease
Manghera, M. (2015) · WinnSpace (University of Winnipeg)
Stem Cells and Transplantation for Retinal Diseases
Adelman, R. A. (2017) · JOJ Ophthalmology · doi:10.19080/jojo.2017.02.555582
Vigilante, A., Laddach, A., Moens, N., Meleckyte, R., Leha, A., Ghahramani, A., Culley, O. J., Kathuria, A., Hurling, C., Vickers, A., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/285627
Modelling severe paediatric aplastic anaemia using induced pluripotent stem cell technology
Melguizo‐Sanchis, D. (2017)
Adhya, D., Massrali, A., Paul, A., Kotter, M., Carroll, J. S., Srivastava, D. P., Price, J., & Baron‐Cohen, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108131797.010
iPSCs for modeling Diamond–Blackfan anemia
Ge, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-822227-0.00004-1
Matveev, A. (2020) · TSpace (University of Toronto)
Induced pluripotent stem cells in the modeling and therapy of lung diseases and airway production
El-Hashash, A. H. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821206-6.00007-2
Genetic studies on congenital heart disorders
Sánchez, A. R., & Juan, J. A. S. (2020) · Nottingham ePrints (University of Nottingham)
Richardson, E., Johnson, R., & Ingles, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820519-8.00008-9
Sawada, T., Barbosa, A. D. L., Araújo, B. H. S., McCord, A. E., D’Ignazio, L., Benjamin, K. J., Feltrin, A. S., Arora, R., Brandtjen, A. C., Kleinman, J. E., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.26.493589
“S9), consistent with previous reports demonstrating iPS cell line specification variation [48,49].”
ResultGu, C. C., Matter, A. M., Turner, A., Aggarwal, P., Yang, W., Sun, X. S., Hunt, S. C., Lewis, C. E., Arnett, D. K., Anson, B. D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.18.584138
A Live-cell Image-based Machine Learning Strategy to Monitor Pluripotent Stem Cell Differentiation
Yang, X., Chen, D., Dang, X., Zhang, J., & Zhao, Y. (2024) · Journal of Visualized Experiments · doi:10.3791/66823
Unbiased identification of cell identity in dense mixed neural culturesPreprint
Beuckeleer, S. D., Looverbosch, T. V. D., Daele, J. V. D., Ponsaerts, P., & Vos, W. H. D. (2024) · eLife · doi:10.7554/elife.95273.2
Unbiased identification of cell identity in dense mixed neural culturesPreprint
Beuckeleer, S. D., Looverbosch, T. V. D., Daele, J. V. D., Ponsaerts, P., & Vos, W. H. D. (2024) · eLife · doi:10.7554/elife.95273.3
MicroRNA profiles of four induced pluripotent stem cell lines derived from distinct tissues
Trakarnsanga, K., Vorasan, N., Tantarungsee, N., Wattanapanitch, M., Vatanashevanopakorn, C., Suktitipat, B., & Metheetrairut, C. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07437-3
Lee, M., Park, J., Kim, Y.-E., Nah, S., Han, M., Heo, C. Y., Nakanishi, M., & Song, J. (2025) · Stem Cell Research · doi:10.1016/j.scr.2025.103821
Setó‐Salvia, N., Houlden, H., & Warner, T. T. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02249-7
“Moreover, iPSC lines from the same individual— or between individuals—can exhibit substantial gene expression heterogeneity, affecting the reproducibility of results [114].”
Lee, M., Kim, Y.-E., Choi, W., Nah, S., Han, M., Heo, C. Y., Nakanishi, M., & Song, J. (2025) · Stem Cell Research · doi:10.1016/j.scr.2025.103891
Harnessing heterogeneity for the rational design of cell manufacturing
Nokoorani, Y. D., Movasat, H., Giacopino, E., Shahdoost, A., Lipsitz, Y. Y., & Shakiba, N. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101458 · Cited by 1
O’Regan, G. C., Farag, S. H., Casey, C. S., Wood‐Kaczmar, A., Pocock, J. M., Tabrizi, S. J., & André, R. (2021) · Figshare · doi:10.6084/m9.figshare.14451028
Cho, Y. K., Kim, H.-K., Kwon, S. S., Jeon, S.-H., Cheong, J.-W., Nam, K. T., Kim, H.-S., Kim, S., & Kim, H. O. (2024) · Figshare · doi:10.6084/m9.figshare.26585247
O’Regan, G. C., Farag, S. H., Casey, C. S., Wood‐Kaczmar, A., Pocock, J. M., Tabrizi, S. J., & André, R. (2021) · Figshare · doi:10.6084/m9.figshare.14451025
Investigating the role of microglia risk genes in Alzheimer’s disease
Vassileva, M. (2023) · ORCA Online Research @Cardiff (Cardiff University)
Bridging Regenerative and Restorative Stem Cell Therapies in Parkinson’s Disease
Onuigbo, C. C., Martínez-Lemus, J. D., Tharp, E., & Schiess, M. C. (2026) · Cells · doi:10.3390/cells15070578
Sansac, C. (2016) · theses.fr (ABES) · doi:10.70675/bfcfe178z1a73z4541zb6cezcea61c89bc4b
“S’il existe une grande variabilité dans les capacités de différenciation des CSP, cette variabilité n’est pas spécifique aux iPSC mais partagée avec les CSE (Osafune et al., 2008) et semble relever du polymorphisme génétique (Rouhani et al., 2014 ; Choi et al., 2015).”
BackgroundFunctional roles of long non coding RNAs in pluripotency and adaptation of stem cells in culture.
Bouckenheimer, J. (2016) · theses.fr (ABES) · doi:10.70675/2a3f43b2zc37az485ezb068z506eee39b7ad
Thérapie génique pour l’amyotrophie spinale à l’aide de vecteur AAV
Besse, A. (2019) · theses.fr (ABES) · doi:10.70675/4c95aab3zb74dz4adbzae72z8c836167d9ba
Fourrier, A. (2019) · theses.fr (ABES) · doi:10.70675/47d480a4z453ez42abzbdb6z8a3aae86f375
Ozturk, T. (2024) · theses.fr (ABES) · doi:10.70675/d4cd23c1ze3c7z4384z8797zd3f77adb09d0
Kumar, S., Aceves, M., Guerra, L., Granados, J., Novilla, E., Juarez, F., Oluwadairo, T., Leandro, A. C., Leandro, M., Peralta, J. M., et al. (2026) · Cells · doi:10.3390/cells15171592
“…epigenetic memory is largely erased during reprogramming, particularly in blood cell-derived iPSCs, the iPSC-based model offers a powerful advantage for mapping genetic determinants of phenotypic variation by effectively controlling for confounding organismal and environmental factors [14].”
Khan, I., Rungsiwiwut, R., Thongphakdee, A., Subboriboon, S., Angchuan, C., Samruan, W., Khalil, A. A. K., & Parnpai, R. (2026) · Biology · doi:10.3390/biology15201833
“Instead, progress should be gauged by achievement of evidence tiers, decreasing frequencies of abnormal outcomes, and reproducibility across independent donors and clones [102].”
Qi, L., Bertucci, T. B., Borden, S. M., Arduini, B. L., Lotz, S., Bowles, K. R., Goate, A., Karch, C. M. M., Temple, S., & Geschwind, D. H. (2026) · Neuron · doi:10.1016/j.neuron.2026.09.022 · Cited by 1
Verma, R. S., Zhang, I., Chen, X., Pierce, M. S., Kumar, S. R., & McCain, M. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.11.758388
“Given the inherent line-to-line genetic and transcriptional heterogeneity of iPSCs 62,63 , our results should be interpreted with caution due to the relatively low number of patient lines.”
Harej, A., Rački, V., Belančić, A., Križ, J., Vitezić, D., Mršić‐Pelčić, J., Acharya, G., Varshney, M., & Pilipović, K. (2026) · Stem Cells International · doi:10.1155/sci/1130043
“While iPSC models can capture the genetic background of individual patients, they cannot easily recapitulate the complex gene – environment interactions that contribute to disease development and progression in vivo [168].”
Ma, Z., Wang, Y., Du, Y., Cao, B., Xu, Y., & Li, H. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1937763
Molecular investigations of age-related macular degeneration
Whitmore, S. S., Anderson, M. G., Sohn, E. H., Scheetz, T. E., Tan, K., & Mullins, R. F. (2015) · doi:10.17077/etd.7xzjf8nh
Metadata
- Authors
- Rouhani, F., Kumasaka, N., de Brito, M. C., Bradley, A., Vallier, L., & Gaffney, D.
- Affiliations
- Wellcome Sanger Institute (GB)
- University of Cambridge (GB)
- Corresponding author
- Gaffney, Daniel
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-06-05
- Volume
- 10
- Issue
- 6
- Pages
- e1004432
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC4046971
- OpenAlex
- W2008485310
- Cited by
- 294
- References
- 35
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 22 · 2023: 22 · 2022: 19 · 2021: 29 · 2020: 25 · 2019: 21 · 2018: 33 · 2017: 37 · 2016: 33 · 2015: 25 · 2014: 5
- FWCI
- 13.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Wellcome Trust (EU-FP7-, 098051)
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- National Institute for Health and Care Research
- Engineering and Physical Sciences Research Council (TS/H001220/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- human induced pluripotent stem cells, transcriptional heterogeneity, epigenetic memory, cell line heterogeneity, disease modeling, personalized medicine
- MeSH terms
- Adult, Base Sequence, Cell Differentiation, Cells, Cultured, Female, Fibroblasts, Humans, Male, Transcription, Genetic, Keratinocytes, Sequence Alignment, Sequence Analysis, RNA, Endothelial Cells, Embryonic Stem Cells, Induced Pluripotent Stem Cells, Epigenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.